Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation (HBSAE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Kaohsiung Veterans General Hospital.
Sponsor:
Information provided by (Responsible Party):
Wei-Lun Tsai, Kaohsiung Veterans General Hospital.
ClinicalTrials.gov Identifier:
NCT01848743
First received: April 24, 2013
Last updated: September 12, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)